Status:
COMPLETED
Cross-cultural Adaptation to the Spanish Population and Validation of the BESTest and Mini-BESTest
Lead Sponsor:
Centro de Referencia Estatal de Atención Al Daño Cerebral
Collaborating Sponsors:
University of Castilla-La Mancha
University of Alcala
Conditions:
Brain Damage
Eligibility:
All Genders
16-54 years
Brief Summary
Due to brain damage acquired (BDA), is often difficulty in gait and balance alterations, as problems that patients designated as the most disabling. It is essential to an effective assessment of the b...
Detailed Description
Marta Fernández Hontoria, physiotherapist at the State Reference Center of Attention to Brain Injury (CEADAC), will develop, together with her team formed by Cristina Lirio Romero and María Torres Lac...
Eligibility Criteria
Inclusion
- The participants will be all Ceadac's users.
- Adults who had suffered a BDA, at least 2 months before.
- The disability before suffering BDA was less than or equal to three on the scale modified Rankin.
- Lack of cognitive impairment scale Minimental State Examination, with a score is \> 24.
- No previous diseases that alter the balance.
- Clinically stable and without fever-
- Ability to walk with technical support or without it.
- Signing an informed consent.
Exclusion
- Medical contraindications to perform physical tests (acute or peripheral nervous system musculoskeletal disorders).
- Not understand the instructions.
- Subjects with severe aphasia.
- Subjects with acute processes of any added pathology.
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04052087
Start Date
March 15 2021
End Date
June 30 2022
Last Update
July 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ceadac
Madrid, Spain, 28034